US Patent Issued to Shanghai Henlius Biotech, Shanghai Henlius Biopharmaceutical, Shanghai Henlius Biologics on May 19 for "Anti-CD47 antibodies and methods of use" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,630, issued on May 19, was assigned to Shanghai Henlius Biotech Inc. (Shanghai), Shanghai Henlius Biopharmaceutical Co. Ltd. (Shanghai) and Shanghai Henlius Biologics Co. Ltd. (Shanghai).

"Anti-CD47 antibodies and methods of use" was invented by Jiin-Tarng Wang (Shanghai), Chi-Ling Tseng (Shanghai) and Wei-Dong Jiang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies and antibody derivatives that bind to CD47 (also known as IAP, MER6 and OA3) and methods of using the same. In certain embodiments, an anti-CD47 antibody or antibody derivative disclosed herein exhibits reduced binding to a red blood cel...